Francis Lo, Chief People Officer, on July 15, 2026, sold 105,762 shares in Adaptive Biotechnologies (ADPT) for $2,389,164. Following the Form 4 filing with the SEC, Lo has control over a total of 233,213 common shares of the company, with 230,713 shares held directly and 2,500 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1478320/000178066026000019/xslF345X05/form4.xml